Tech Company Financing Transactions
Thermalin Diabetes Funding Round
Thermalin Diabetes, based in Cleveland, secured $2.3 million in investment from private investors.
Transaction Overview
Company Name
Announced On
8/9/2019
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$2,337,021
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10000 Cedar Ave.
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Overview
Thermalin Diabetes Inc. is developing a portfolio of insulin analogs to address both the fast-acting and long-acting insulin markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Brooks
Chief Executive Officer
Richard Berenson
Chief Financial Officer
Bryan Keaney
Chief Scientific Officer
Dod Michael
Founder
Michael Weiss
VP - Bus. Development
Bruce Frank
VP - R & D
Thomas Hattier
Browse more venture capital transactions:
Prev: 8/9/2019: StateSpace venture capital transaction
Next: 8/9/2019: Beynd venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs